Neurobehavioral Phenotype of Kabuki Syndrome: Anxiety is a Common Feature

Overview

Journal Front Genet

Date 2022 Oct 24

PMID 36276984

Authors

Allison J Kalinousky

Tyler Rapp

Hadia Hijazi

Jennifer Johnson

Hans Tomas Bjornsson

Jacqueline R Harris

Affiliations

Soon will be listed here.

Abstract

Kabuki syndrome (KS) is a Mendelian Disorder of the Epigenetic Machinery (MDEM) caused by loss of function variants in either of two genes involved in the regulation of histone methylation, (34-76%) or (9-13%). Previously, representative neurobehavioral deficits of KS were recapitulated in a mouse model, emphasizing the role of KMT2D in brain development, specifically in ongoing hippocampal neurogenesis in the granule cell layer of the dentate gyrus. Interestingly, anxiety, a phenotype that has a known association with decreased hippocampal neurogenesis, has been anecdotally reported in individuals with KS. In this study, anxiety and behavior were assessed in a cohort of 60 individuals with molecularly confirmed KS and 25 unaffected biological siblings, questionnaires (SCARED/GAS-ID and CBCL/ABCL). Participant age ranged from 4 to 43 years old, with 88.3% of participants having a pathogenic variant in , and the rest having variants in . In addition, data was collected on adaptive function and positive affect/quality of life in participants with KS using appropriate online surveys including ABAS-III and PROMIS Positive Affect. Survey scores were compared within the KS participants across age groups and between KS participants and their unaffected siblings. We found that children with KS have significantly higher anxiety scores and total behavior problem scores than their unaffected siblings ( = 0.0225, < 0.0001). Moreover, a large proportion of affected individuals (22.2% of children and 60.0% of adults) surpassed the established threshold for anxiety; this may even be an underestimate given many patients are already treated for anxiety. In this sample, anxiety levels did not correlate with level of cognitive or adaptive function in any KS participants, but negatively correlated with positive affect in children with KS ( = 0.0005). These findings indicate that anxiety is a common neurobehavioral feature of KS. Providers should therefore carefully screen individuals with KS for anxiety as well as other behavioral issues in order to allow for prompt intervention. Neurobehavioral anxiety measures may also prove to be important outcome measures for clinical trials in KS.

Citing Articles

Higher order interaction analysis quantifies coordination in the epigenome revealing novel biological relationships in Kabuki syndrome.

Cuvertino S, Garner T, Martirosian E, Walusimbi B, Kimber S, Banka S Brief Bioinform. 2024; 26(1).

PMID: 39701600 PMC: 11658816. DOI: 10.1093/bib/bbae667.

Navigating the transition of care in patients with inborn errors of immunity: a single-center's descriptive experience.

Mejia Gonzalez M, Quijada Morales P, Escobar M, Juarez Guerrero A, Seoane-Reula M Front Immunol. 2023; 14:1263349.

PMID: 37854610 PMC: 10579936. DOI: 10.3389/fimmu.2023.1263349.

Associations Between Executive Functioning, Behavioral Functioning, and Adaptive Functioning Difficulties in Wiedemann-Steiner Syndrome.

Ng R, Bjornsson H, Fahrner J, Harris J Arch Clin Neuropsychol. 2023; 39(2):186-195.

PMID: 37565480 PMC: 10879922. DOI: 10.1093/arclin/acad060.

Epigenetics of cognition and behavior: insights from Mendelian disorders of epigenetic machinery.

Ng R, Kalinousky A, Harris J J Neurodev Disord. 2023; 15(1):16.

PMID: 37245029 PMC: 10224589. DOI: 10.1186/s11689-023-09482-0.

Anxiety in Wiedemann-Steiner syndrome.

Ng R, Bjornsson H, Fahrner J, Harris J Am J Med Genet A. 2022; 191(2):437-444.

PMID: 36373844 PMC: 9907226. DOI: 10.1002/ajmg.a.63040.

References

Aref-Eshghi E, Schenkel L, Lin H, Skinner C, Ainsworth P, Pare G . The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance. Epigenetics. 2017; 12(11):923-933. PMC: 5788422. DOI: 10.1080/15592294.2017.1381807. View

Alarcon J, Malleret G, Touzani K, Vronskaya S, Ishii S, Kandel E . Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron. 2004; 42(6):947-59. DOI: 10.1016/j.neuron.2004.05.021. View

Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T . Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981; 99(4):565-9. DOI: 10.1016/s0022-3476(81)80255-7. View

Stern J, Gadgil M, Blakeley-Smith A, Reaven J, Hepburn S . Psychometric Properties of the SCARED in Youth with Autism Spectrum Disorder. Res Autism Spectr Disord. 2014; 8(9):1225-1234. PMC: 4136967. DOI: 10.1016/j.rasd.2014.06.008. View

Korzus E, Rosenfeld M, Mayford M . CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron. 2004; 42(6):961-72. PMC: 8048715. DOI: 10.1016/j.neuron.2004.06.002. View

Niikawa N, Kuroki Y, Kajii T, Matsuura N, Ishikiriyama S, Tonoki H . Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet. 1988; 31(3):565-89. DOI: 10.1002/ajmg.1320310312. View

Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I . A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr. 1981; 99(4):570-3. DOI: 10.1016/s0022-3476(81)80256-9. View

Reardon T, Gray K, Melvin G . Anxiety disorders in children and adolescents with intellectual disability: Prevalence and assessment. Res Dev Disabil. 2014; 36C:175-190. DOI: 10.1016/j.ridd.2014.10.007. View

Schulz Y, Freese L, Manz J, Zoll B, Volter C, Brockmann K . CHARGE and Kabuki syndromes: a phenotypic and molecular link. Hum Mol Genet. 2014; 23(16):4396-405. DOI: 10.1093/hmg/ddu156. View

10.

Forrest C, Ravens-Sieberer U, Devine J, Becker B, Teneralli R, Moon J . Development and Evaluation of the PROMIS Pediatric Positive Affect Item Bank, Child-Report and Parent-Proxy Editions. J Happiness Stud. 2018; 19(3):699-718. PMC: 5947961. DOI: 10.1007/s10902-016-9843-9. View

11.

Harris J, Mahone E, Bjornsson H . Molecularly confirmed Kabuki (Niikawa-Kuroki) syndrome patients demonstrate a specific cognitive profile with extensive visuospatial abnormalities. J Intellect Disabil Res. 2019; 63(6):489-497. PMC: 6499655. DOI: 10.1111/jir.12596. View

12.

Royston R, Howlin P, Waite J, Oliver C . Anxiety Disorders in Williams Syndrome Contrasted with Intellectual Disability and the General Population: A Systematic Review and Meta-Analysis. J Autism Dev Disord. 2016; 47(12):3765-3777. PMC: 5676825. DOI: 10.1007/s10803-016-2909-z. View

13.

Lohr W, Daniels K, Wiemken T, Williams P, Kelley R, Kuravackel G . The Screen for Child Anxiety-Related Emotional Disorders Is Sensitive but Not Specific in Identifying Anxiety in Children with High-Functioning Autism Spectrum Disorder: A Pilot Comparison to the Achenbach System of Empirically Based Assessment.... Front Psychiatry. 2017; 8:138. PMC: 5539181. DOI: 10.3389/fpsyt.2017.00138. View

14.

Cassano G, Baldini Rossi N, Pini S . Psychopharmacology of anxiety disorders. Dialogues Clin Neurosci. 2011; 4(3):271-85. PMC: 3181684. View

15.

Theodore-Oklota C, Hartman D, Hoffman D, Bjornsson H . A Qualitative Study to Characterize the Humanistic Burden of Kabuki Syndrome in the United States and Canada. Adv Ther. 2021; 39(1):619-631. PMC: 8799562. DOI: 10.1007/s12325-021-01953-x. View

16.

Van Laarhoven P, Neitzel L, Quintana A, Geiger E, Zackai E, Clouthier D . Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet. 2015; 24(15):4443-53. PMC: 4492403. DOI: 10.1093/hmg/ddv180. View

17.

Bjornsson H, Benjamin J, Zhang L, Weissman J, Gerber E, Chen Y . Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med. 2014; 6(256):256ra135. PMC: 4406328. DOI: 10.1126/scitranslmed.3009278. View

18.

Benjamin J, Pilarowski G, Carosso G, Zhang L, Huso D, Goff L . A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. Proc Natl Acad Sci U S A. 2016; 114(1):125-130. PMC: 5224378. DOI: 10.1073/pnas.1611431114. View

19.

Mindham J, Espie C . Glasgow Anxiety Scale for people with an Intellectual Disability (GAS-ID): development and psychometric properties of a new measure for use with people with mild intellectual disability. J Intellect Disabil Res. 2003; 47(Pt 1):22-30. DOI: 10.1046/j.1365-2788.2003.00457.x. View

20.

Taupin P . Neurogenesis and the effect of antidepressants. Drug Target Insights. 2011; 1:13-7. PMC: 3155214. View